Pharming to present at the Guggenheim Healthcare Talks - Genomic Medicines and Rare Disease Days

Rhea-AI Summary

Pharming Group N.V. announced participation in the Guggenheim Healthcare Talks focused on Genomic Medicines and Rare Disease Days, scheduled for April 3-4, 2023, in New York. CEO Sijmen de Vries and CCO Stephen Toor will feature in a fireside chat on April 3 at 15:20 ET. Interested investors can access a live webcast and replay on Pharming's website. Additionally, they will be available for one-on-one meetings during the conference. Pharming is dedicated to developing treatments for rare diseases and operates globally, serving patients in over 30 markets.

LEIDEN, The Netherlands, March 30, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming's Chief Executive Officer, Sijmen de Vries, and Chief Commercial Officer, Stephen Toor, will attend the Guggenheim Healthcare Talks | Genomic Medicines and Rare Disease Days, April 3 - 4, 2023 in New York.

 

Pharming's CEO and CCO will take part in a fireside chat on April 3 at 15:20 ET /21:20 CEST.

A live webcast and replay of the fireside chat can be found in the "Upcoming Events" and "News" sections of Pharming's website.

Pharming's CEO and CCO will be available for one-to-one investor meetings during the conference.

For more information about the conference, or to schedule a one-to-one with Pharming's management team, please contact your Guggenheim representative, or send an email to Pharming's Investor Relations team to investor@pharming.com.

About Pharming Group N.V.

Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming is headquartered in Leiden, Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific. For more information, visit www.pharming.com or follow us on LinkedIn.

Logo - https://mma.prnewswire.com/media/1778344/Pharming_Group_NV_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/pharming-to-present-at-the-guggenheim-healthcare-talks--genomic-medicines-and-rare-disease-days-301786069.html

SOURCE Pharming

FAQ

What is Pharming Group's participation in the Guggenheim Healthcare Talks?

Pharming Group N.V. will participate in the Guggenheim Healthcare Talks on Genomic Medicines and Rare Disease Days on April 3-4, 2023.

When will Pharming's CEO speak at the conference?

Pharming's CEO, Sijmen de Vries, will speak during a fireside chat on April 3, 2023, at 15:20 ET.

Where can I watch the Pharming fireside chat?

The fireside chat can be accessed via live webcast on Pharming's website.

How can investors schedule a meeting with Pharming's management?

Investors can schedule a one-on-one meeting with Pharming's management during the conference by contacting their Guggenheim representative or emailing investor relations.

What is the focus of Pharming Group's business?

Pharming Group N.V. focuses on developing treatments for rare and life-threatening diseases through innovative therapies.